![Separator Separator](https://www.ceoinsightsindia.com/images/line.png)
Tata 1mg and Vitonnix UK Forge Exclusive Partnership in India
![Separator Separator](https://www.ceoinsightsindia.com/images/line.png)
Tata 1mg, a reputable digital healthcare platform in India, has partnered with Vitonnix UK, a prominent innovator in health and wellness, to introduce a pioneering product in the Indian market. Together, they have unveiled an innovative line of Vitamin Sublingual Sprays. These sprays are administered under the tongue, facilitating direct absorption of vitamins and supplements through the mouth's mucosal lining, which possesses a dense blood supply.
The initial phase of the launch features four notable products: Vitamin D, Multivitamins, Biotin, and the highlight of the lineup, Melatonin. These sublingual sprays aim to provide an effortless and efficient method for individuals to incorporate their daily vitamin and health supplements. Saurabh Goel, Vice President - Category Management at Tata 1mg, expressed excitement about this impactful collaboration.
"At Tata 1mg, our core focus has consistently revolved around our customers' well-being. Recognizing the significance of healthcare innovation, and following a thorough assessment of Vitonnix UK's extensive research and development endeavors, we are confident that these Vitamin Sublingual Sprays will empower individuals to manage their health conveniently in new ways".
Satish Subramani, Managing Partner at Vitonnix UK, commented: "We're excited to introduce our cutting-edge Vitamin Sublingual Sprays to India through our collaboration with Tata 1mg. This partnership underscores our dedication to delivering innovative health solutions that are effective and convenient to the Indian market. Our association with Tata 1mg, a trusted digital healthcare brand in India, underscores the quality and reliability of our products".